Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Clinical characteristics of patients with suspected cardiac chest pain and angiographically normal coronary arteries in a secondary care hospital.

de Lange TS, Tijssen RYG, Damman P, van Bergen PFMM.

Neth Heart J. 2017 Jun;25(6):370-375. doi: 10.1007/s12471-017-0988-x.

2.

Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.

Lieve KV, Verkerk AO, Podliesna S, van der Werf C, Tanck MW, Hofman N, van Bergen PF, Beekman L, Bezzina CR, Wilde AAM, Lodder EM.

Int J Cardiol. 2017 Jun 1;236:187-193. doi: 10.1016/j.ijcard.2017.01.113. Epub 2017 Jan 29.

3.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
4.

Cardiac tamponade by myocardial rupture after acute myocardial infarction prevented by old thorax trauma.

Haeck JD, Winter MM, van Bergen PF, Dekkers P.

Eur Heart J Cardiovasc Imaging. 2013 May;14(5):505. doi: 10.1093/ehjci/jes244. Epub 2012 Nov 15. No abstract available.

PMID:
23161789
5.

Takotsubo cardiomyopathy shortly following pacemaker implantation-case report and review of the literature.

Postema PG, Wiersma JJ, van der Bilt IA, Dekkers P, van Bergen PF.

Neth Heart J. 2014 Oct;22(10):456-9. doi: 10.1007/s12471-012-0320-8.

6.

Social burden and lifestyle in adults with congenital heart disease.

Zomer AC, Vaartjes I, Uiterwaal CS, van der Velde ET, Sieswerda GJ, Wajon EM, Plomp K, van Bergen PF, Verheugt CL, Krivka E, de Vries CJ, Lok DJ, Grobbee DE, Mulder BJ.

Am J Cardiol. 2012 Jun 1;109(11):1657-63. doi: 10.1016/j.amjcard.2012.01.397. Epub 2012 Mar 23.

PMID:
22444325
7.

Two cases of left-sided and concomitant right-sided endocarditis: potential pathways of spreading.

van der Zee PM, van Bergen PF, Dekkers P, van den Brink RB.

Neth Heart J. 2012 Nov;20(11):472-4. doi: 10.1007/s12471-011-0200-7. No abstract available.

8.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

9.

Lasso technique for retrieving a broken, dislocated port-a-cath fragment.

Bindraban NR, van de Klippe HA, van Bergen PF, Basart DC.

Neth Heart J. 2009 Feb;17(2):75-6. No abstract available.

10.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
11.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

13.

Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction.

van Domburg RT, Deckers JW, van Bergen PF, Azar AJ, Jonker JJ, Simoons ML.

Neth Heart J. 2001 Aug;9(4-5):166-171.

14.

Evidence for demethylation of syringyl moieties in archaeological wood using pyrolysis-gas chromatography/mass spectrometry.

van Bergen PF, Poole I, Ogilvie TM, Caple C, Evershed RP.

Rapid Commun Mass Spectrom. 2000;14(2):71-9.

PMID:
10623932
15.

[Bilateral blood pressure measurement before and after coronary bypass surgery: an absolute necessity].

Ernst JM, van Bergen PF, Schepens MA, Brutel de la Rivière A, Plokker HW.

Ned Tijdschr Geneeskd. 1999 Sep 11;143(37):1849-53. Dutch.

PMID:
10526596
16.

The Cardiac Infarction Injury Score as a predictor for long-term mortality in survivors of a myocardial infarction.

van Domburg RT, Klootwijk P, Deckers JW, van Bergen PF, Jonker JJ, Simoons ML.

Eur Heart J. 1998 Jul;19(7):1034-41.

PMID:
9717038
17.

Optimal intensity of oral anticoagulant therapy after myocardial infarction.

Azar AJ, Cannegieter SC, Deckers JW, Briët E, van Bergen PF, Jonker JJ, Rosendaal FR.

J Am Coll Cardiol. 1996 May;27(6):1349-55.

18.

Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.

Azar AJ, Koudstaal PJ, Wintzen AR, van Bergen PF, Jonker JJ, Deckers JW.

Ann Neurol. 1996 Mar;39(3):301-7.

PMID:
8602748
19.

Recognition of chitin and proteins in invertebrate cuticles using analytical pyrolysis/gas chromatography and pyrolysis/gas chromatography/mass spectrometry.

Stankiewicz BA, Van Bergen PF, Duncan IJ, Carter JF, Briggs DE, Evershed RP.

Rapid Commun Mass Spectrom. 1996;10(14):1747-57.

PMID:
8953778
20.

Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction.

van Bergen PF, Deckers JW, Jonker JJ, van Domburg RT, Azar AJ, Hofman A.

Br Heart J. 1995 Aug;74(2):117-21.

Supplemental Content

Loading ...
Support Center